Chimerix to Report First Quarter 2023 Financial Results and Provide an Operational Update on May 4, 2023

Rhea-AI Summary

Chimerix (NASDAQ:CMRX) will host a live conference call on May 4, 2023, at 8:30 a.m. ET to report its financial results for Q1 2023, which ended March 31, 2023. The call will provide a business overview alongside the financial disclosures. Investors can participate by calling (646) 307-1963 domestically or (800) 715-9871 internationally, referring to conference ID 8594205. A live audio webcast will also be available on Chimerix's website, with an archived version accessible two hours post-event.

Chimerix is focused on developing medicines for severe diseases, centered around its advanced clinical program, ONC201, aimed at treating H3 K27M-mutant glioma.

DURHAM, N.C., April 27, 2023 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Thursday, May 4, 2023 at 8:30 a.m. ET to report financial results for the first quarter ended March 31, 2023, and to provide a business overview.

To access the live conference call, please dial (646) 307-1963 (domestic) or (800) 715-9871 (international) at least five minutes prior to the start time, and refer to conference ID 8594205. A live audio webcast of the call will also be available on the Investors’ section of the Company's website, www.chimerix.com. An archived webcast will be available on the Chimerix website approximately two hours after the event.

About Chimerix

Chimerix is a biopharmaceutical company with a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The Company’s most advanced clinical-stage development program, ONC201, is in development for H3 K27M-mutant glioma.

CONTACTS:
        
Michelle LaSpaluto
919 972-7115
ir@chimerix.com

Will O’Connor
Stern Investor Relations
212-362-1200
will@sternir.com

 

FAQ

What is Chimerix's financial results announcement date for Q1 2023?

Chimerix will announce its financial results for Q1 2023 on May 4, 2023.

How can I access Chimerix's Q1 2023 financial call?

You can access Chimerix's Q1 2023 financial call by dialing (646) 307-1963 domestically or (800) 715-9871 internationally, using conference ID 8594205.

What is ONC201 in relation to Chimerix's business?

ONC201 is Chimerix's most advanced clinical-stage development program, targeting H3 K27M-mutant glioma.

Where can I find the archived version of Chimerix's financial results call?

The archived version of Chimerix's financial results call will be available on their website approximately two hours after the live event.